14-day Premium Trial Subscription Try For FreeTry Free
$34.58
+0.92 (+2.73%)
At Close: May 02, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $27.14 $35.36 Thursday, 2nd May 2024 AGIO stock ended at $34.58. This is 2.73% more than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 6.63% from a day low at $33.16 to a day high of $35.36.
90 days $22.41 $35.48
52 weeks $19.80 $35.48

Historical Agios Pharmaceuticals prices

Date Open High Low Close Volume
Nov 04, 2021 $49.99 $50.98 $45.79 $46.17 554 710
Nov 03, 2021 $49.00 $50.26 $45.63 $49.64 778 245
Nov 02, 2021 $49.90 $49.90 $48.58 $49.78 243 316
Nov 01, 2021 $47.10 $49.75 $46.90 $49.62 261 087
Oct 29, 2021 $48.36 $48.77 $46.91 $47.00 249 941
Oct 28, 2021 $47.14 $48.46 $47.02 $48.40 407 886
Oct 27, 2021 $48.15 $48.20 $46.84 $46.99 270 697
Oct 26, 2021 $48.96 $49.12 $47.97 $48.02 278 469
Oct 25, 2021 $48.74 $49.45 $48.00 $48.89 286 643
Oct 22, 2021 $48.19 $48.75 $47.26 $48.55 320 517
Oct 21, 2021 $47.65 $48.44 $47.25 $47.99 338 640
Oct 20, 2021 $46.00 $47.68 $45.49 $47.58 304 849
Oct 19, 2021 $44.82 $45.94 $44.53 $45.82 241 709
Oct 18, 2021 $45.89 $46.19 $43.65 $44.28 365 780
Oct 15, 2021 $47.23 $47.40 $46.06 $46.28 813 734
Oct 14, 2021 $46.23 $47.40 $45.90 $46.73 309 589
Oct 13, 2021 $45.41 $46.43 $45.35 $45.53 291 509
Oct 12, 2021 $44.24 $45.97 $43.99 $45.54 332 837
Oct 11, 2021 $44.05 $45.08 $43.82 $44.31 291 540
Oct 08, 2021 $44.03 $44.60 $43.42 $44.17 206 505
Oct 07, 2021 $43.48 $44.66 $43.28 $44.02 414 774
Oct 06, 2021 $43.46 $44.03 $42.85 $43.31 323 287
Oct 05, 2021 $45.48 $45.56 $43.58 $43.93 534 790
Oct 04, 2021 $46.21 $47.13 $45.17 $45.53 604 305
Oct 01, 2021 $46.04 $46.89 $44.87 $46.34 467 093
Click to get the best stock tips daily for free!

About Agios Pharmaceuticals

Agios Pharmaceuticals Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Ph... AGIO Profile

Golden Star

Ticker Date Change Price
BSCQ Apr 30 0.393% $19.09
EQC Apr 30 1.76% $18.72
HRB Apr 30 1.69% $47.23
REG Apr 30 1.35% $59.22
INGR Apr 30 0.576% $114.59
BSJP Apr 29 0.175% $22.91
LYG Apr 29 0.781% $2.56
ORA Apr 29 3.46% $64.48
DHT Apr 24 4.34% $11.28
LPLA Apr 19 2.62% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT